Skip to main content
Clinical Trials/NCT01800708
NCT01800708
Completed
Not Applicable

The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery

Fundação Altino Ventura1 site in 1 country60 target enrollmentJanuary 2010

Overview

Phase
Not Applicable
Intervention
Prednisolone syrup
Conditions
Cataract
Sponsor
Fundação Altino Ventura
Enrollment
60
Locations
1
Primary Endpoint
Visual axis obscuration
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The aim of the present study is to investigate the outcomes of congenital cataract surgery when injecting intraoperative intracameral triamcinolone versus the postoperative use of oral prednisolone.

This is a prospective, randomized clinical trial. Sixty children will be submitted to congenital cataract surgery younger than 2 years of age. They will be randomly divided in two groups. The study group will receive an intraoperative intracameral triamcinolone acetonide injection. The control group will receive prednisolone syrup postoperatively. The surgical outcomes will be assessed after one year.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
March 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundação Altino Ventura
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients younger than 2 years of age
  • Unilateral or bilateral congenital cataracts compromising the red reflex

Exclusion Criteria

  • Corneal opacity
  • Subluxated cataract
  • Traumatic cataract
  • Complex microphthalmia
  • Persistant hyperplastic primary vitreous
  • Retinal detachment
  • Patients with intraoperative complications, such as IOL implanted in the sulcus

Arms & Interventions

Prednisolone syrup

The control group will receive prednisolone syrup postoperatively

Intervention: Prednisolone syrup

Triamcinolone acetonide

The study group will receive an intraoperative intracameral injection of triamcinolone acetonide

Intervention: Triamcinolone acetonide

Outcomes

Primary Outcomes

Visual axis obscuration

Time Frame: 1 year after surgery

Visual axis obscuration will be evaluated under sedation, with a dilated pupil. All patients will be classified by the principal investigator as having or not a significant visual axis obscuration, based on the red reflex.

Intraocular pressure

Time Frame: 1 year after surgery

Study Sites (1)

Loading locations...

Similar Trials